Patent · US Active

Zika virus vaccine

US11219681B2 · kind B2 · utility

8Cited by

6References

26Claims

0Family size

Assignee

Valneva Austria GmbH · AT

Inventors

Jana Barbero Calzado · Wien, AT
Mario Nebenführ · Wien, AT
Robert Schlegl · Siegenfeld, AT
Michael Weber · Wien, AT
Jürgen Heindl-Wruss · Wien, AT

Key dates

Filing date	Mar 10, 2020
Grant date	Jan 11, 2022
Priority date	—
Expiry date	Mar 10, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are Zika virus vaccines and compositions and methods of producing and administering said vaccines to subjects in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.